Differences in intracellular localisation of ANKH mutants that relate to mechanisms of calcium pyrophosphate deposition disease and craniometaphyseal dysplasia by Vijen, Sunny et al.
1Scientific RepoRtS |         (2020) 10:7408  | https://doi.org/10.1038/s41598-020-63911-x
www.nature.com/scientificreports
Differences in intracellular 
localisation of ANKH mutants that 
relate to mechanisms of calcium 
pyrophosphate deposition disease 
and craniometaphyseal dysplasia
Sunny Vijen1, Chris Hawes1,3, John Runions1, R. Graham G. Russell2, B. Paul Wordsworth2, 
Andrew J. Carr2, Ryan C. Pink1 ✉ & Yun Zhang1 ✉
ANKH mutations are associated with calcium pyrophosphate deposition disease and craniometaphyseal 
dysplasia. This study investigated the effects of these ANKH mutants on cellular localisation and 
associated biochemistry. We generated four ANKH overexpression-plasmids containing either calcium 
pyrophosphate deposition disease or craniometaphyseal dysplasia linked mutations: P5L, E490del and 
S375del, G389R. They were transfected into CH-8 articular chondrocytes and HEK293 cells. The ANKH 
mutants dynamic differential localisations were imaged and we investigated the interactions with 
the autophagy marker LC3. Extracellular inorganic pyrophosphate, mineralization, ENPP1 activity 
expression of ENPP1, TNAP and PIT-1 were measured. P5L delayed cell membrane localisation but once 
recruited into the membrane it increased extracellular inorganic pyrophosphate, mineralization, and 
ENPP1 activity. E490del remained mostly cytoplasmic, forming punctate co-localisations with LC3, 
increased mineralization, ENPP1 and ENPP1 activity with an initial but unsustained increase in TNAP 
and PIT-1. S375del trended to decrease extracellular inorganic pyrophosphate, increase mineralization. 
G389R delayed cell membrane localisation, trended to decrease extracellular inorganic pyrophosphate, 
increased mineralization and co-localised with LC3. Our results demonstrate a link between 
pathological localisation of ANKH mutants with different degrees in mineralization. Furthermore, 
mutant ANKH functions are related to synthesis of defective proteins, inorganic pyrophosphate 
transport, ENPP1 activity and expression of ENPP1, TNAP and PIT-1.
Under normal conditions cartilage and bone calcification involves  hydroxyapatite (HA) deposition requiring the 
non-enzymatic reaction of extracellular calcium and inorganic phosphate (ePi). In rheumatologic conditions like 
calcium pyrophosphate dihydrate deposition disease (CPPDD) calcium pyrophosphate dihydrate (CPPD) can 
deposit contributed by Inorganic pyrophosphate (PPi), a regulator of calcification, inhibiting HA deposition. At 
least four proteins influence PPi homeostasis in the extracellular matrix (ECM): these include the transmembrane 
pyrophosphate transporter ANKH (the human homologue to the mouse progressive ankylosis protein), ENPP1 
(ectonucleotide pyrophosphatase 1), TNAP (tissue nonspecific alkaline phosphatase, one of the four forms of 
alkaline phosphatase ALPL) and PIT-1 (sodium-dependent phosphate transport 1, also named as SLC20A1); 
ENPP1 readily hydrolyses extracellular adenosine triphosphate (eATP) into extracellular PPi (ePPi) and extra-
cellular AMP (eAMP), whilst ANKH exports intracellular PPi (iPPi) into the ECM, TNAP hydrolyses ePPi into 
extracellular Pi(ePi), and PIT-1 imports ePi into the cell via a sodium exchange channel to be used in metabolic 
pathways1,2.
ANKH is mainly expressed at the cell membrane and mutations in ANKH cause two distinct conditions - 
CPPDD [MIM118600] and craniometaphyseal dysplasia (CMD [MIM123000])3,4. CPPDD typically presents 
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with destructive arthritis and may mimic rheumatoid arthritis, gout or osteoarthritis and is the commonest form 
of inflammatory monoarthritis in the elderly, occurring in up to 40% of those over 65 years of age1,5. In contrast, 
CMD is a rare disorder characterised by hyperostosis/sclerosis of the skull and abnormal modelling of the long 
bones, and individuals with severe forms of CMD can have reduced life expectancy as a result of compression 
of the foramen magnum4. CMD is associated with decreased ePPi, which allows increased HA deposition and 
altered bone modelling via chondrogenesis, osteoblastogenesis and osteoclastogenesis6. There is currently no 
specific treatment for CPPDD and CMD.
Mutations near either end of ANKH are mostly associated with CPPDD while mutations in the middle 
have been reported to cause CMD, though their biological effect and cellular function remain largely unex-
plored. Previous research shows CPPDD associated P5L (p.Pro5Leu, NM_054027.4:c.14 C > T) to increase 
expression of ANKH and was reported to increase expression and activity of ENPP17,8. E490del (p.Glu490del, 
NM_054027.4:c.1468_1470delGAG) deregulated TNAP activity9,10. CMD related mutants have largely been 
restricted to clinical case studies. One case report of S375del (p.Ser375del, NM_054027.4:c.1123_1125delTCC) 
showed a decrease in ePPi that was consistent with the predicted loss-of-function11. G389R (p.Gly389Arg, 
NM_054027.4:c.1165 G > A), reported in several cases of CMD and recently in CPPDD, where it was predicted 
to be a loss-of-function variant4,12.
Autophagy is a dynamic catabolic mechanism that recycles damaged organelles and non-functional proteins 
and maintains cellular homeostasis13. Previous studies have highlighted the importance of autophagy and its 
modulation of genes in maintaining healthy chondrocytes in the formation of cartilage and preventing degener-
ation during osteoarthritis14,15.
To investigate the pathogenic mechanisms of ANKH in CPPDD and CMD, we generated four 
disease-associated ANKH mutants associated with relatively severe clinical phenotypes: two are terminally posi-
tioned P5L and E490del associated with CPPDD, two are centrally positioned S375del and G389R associated 
with CMD. We used confocal imaging to identify ANKH mutant cell localisation dynamics, measured ePPi con-
centrations and altered mineralization level, evaluated ANKH mutant effect on the function of ENPP1 and gene 
expression of ENPP1, TNAP and PIT-1. We also investigated the involvement of autophagy for potential mutated 
ANKH protein recycling in the pathogenesis of CPPDD and CMD.
Results
We found that ANKH mutations altered cellular localisation dynamics and led to biochemical changes at dif-
ferent levels by comparing with wt.ANKH. Our detailed findings are summarised in Table 1 and the details are 
described as below.
Wt.ANKH localisation to the cell membrane and its influence on the expression levels of ENPPI, 
TNAP and PIT-1. Wt.ANKH with GFP at either the N or C terminal showed clear localisation to the cell 
membrane and perinuclear area in HEK293 cells as reported in other cell types such as osteoblastic MC3T3-E1, 
Time 
(H)
HEK293 CH-8
Cells with membrane 
expression (n > 100)
ePPi 
(µM)
Expression (fold change) Mineralization 
(nM)
ENPP1 Activity 
(fold change)ENPP1 TNAP PIT-1
wt.ANKHa
24 57% NA 0.49# 0.56 0.79 0.7**
48 66% 2.6* 2.4* 1.28 1.29 1.93**
72 66% 3.2* 1.6* 0.61 2.32* 1.05
96 37.15**
P5Lb
24 34% NA 1.48 1.72* 1.02 1.92**
48 64% 2.2 1.38 0.76 1.26 1.54**
72 73% 6.9* 1.11 1.39# 1.12 3.39**
96 44.64**
S375delb
24 0% NA 1.62# 1.95# 0.93 1.14**
48 0% 3.1 0.91 0.72 1.88* 0.65**
72 0% 1.8# 1.06 1.21 0.89 1.02
96 52.68**
G389Rb
24 28% NA 2.28* 1.08 1.22 1.93**
48 66% 1.3 0.64 0.65 1.39 0.59**
72 72% 2.6 0.72 1.26 0.74 0.74**
96 40.62**
E490delb
24 35% NA 5.82** 2.79** 2.13* 5.33**
48 7% 1.1 0.89 0.86 1.77# 0.85
72 29% 3.7 0.8 1.07 0.85 1.01
96 42.79**
Table 1. Summary of ANKH mutant effects. aFold change of wt. ANKH is compared to null vector controls, 
bmutant ANKH to wt. ANKH. H: hours after transfection/induction of mineralization. *p value < 0.05, **p 
value < 0.01, #p value 0.05 < 0.1.
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human adult fibroblasts (HAF), adenocarcinomic human alveolar basal epithelial cells (A549), HeLa and mon-
key Cos7 cells (Figs. 1A, S1)16,17. We observed this specific cell membrane localisation in the majority of trans-
fected cells at all-time points after transfection, unlike any other mutant. Further clarification using 3D confocal 
Z-stack rotating rendering also showed the localisation was primarily found in the cell membrane (Movie S1). 
CH-8 cells displayed auto-fluorescence that masked overexpression of control eGFP and wt.ANKH-eGFP (Fig. S2 
and Movie S2). Overexpressing wt.ANKH in HEK293 cells increased ePPi following 48 hours after transfection 
(Fig. 1B). Interestingly, wt.ANKH overexpression in CH-8 cells significantly decreased mineralization com-
pared to GFP only control (Fig. 1C). Wt.ANKH in HEK293 cells showed gene expression of ENPP1 significantly 
increased at 48 and 72 hours, peaking at 48 hours (Fig. 1D), this pattern was mirrored in the ENPP1 activity 
of CH-8 cells (Fig. 1G). A similar, but non-significant trend, was measured for TNAP at 24, and 72 hours after 
Figure 1. Wt.ANKH overexpression intracellular localisation and biochemical effects of overexpression 
compared to null vector control in CH-8 and HEK293 cells. Wt.ANKH-GFP (green) in HEK293 cell membrane 
(A); increased ePPi in HEK293 culture media (B); Alizarin red S staining of CH-8 cells (left) and concentration 
of ARS/µg protein (right) normalized to ActB confirming reduction in mineralization (C); qPCR in transfected 
HEK293 cells trended to decrease ENPP1 at 24 H and increase at 48 and 72 H (D), did not significantly change 
TNAP (E), increased PIT-1 72 H (F); ENPP1 activity in CH-8 cells decreased at 24 H and increased at 48 H (G). 
H = hours, scale bars = 20 μm; *** indicates p value < 0.01; * indicates p value < 0.05. # indicates p value < 
0.1; neg. = Negligible/Raw value below threshold.
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transfection (Fig. 1E). PIT-1 increased significantly at 72 hours (Fig. 1F). Wt. ANKH-eGFP did not co-localise 
with pmRFP-LC3 under autophagic or rescue conditions (Fig. S3).
P5L ANKH slowed initial membrane recruitment and increased ePPi and mineralization via 
increased ENPP1 activity. We observed an initial diffuse expression of P5L within the cytoplasm with peri-
nuclear aggregation and formation of vesicle like structures at 24 hours, with only 34% of HEK293 cells displaying 
specific cell membrane localisation, but returned to wild-type levels at 48 and 72 hours (Fig. 2A). P5L significantly 
increased ePPi double that of wild-type control at 72 hours in HEK293 cells and mineralization increased 20% 
in CH-8 cells (Fig. 2B,C). It also increased TNAP in HEK293 cells but did not change PIT-1 (Fig. 2E,F). In CH-8 
cells we observed insignificant increases in ENPP1 expression, but ENPP1 activity as consistently high at all-time 
points (Fig. 2D,G).
S375del completely abolished ANKH localisation to the cell membrane, decreased ePPi and 
increased mineralization. S375del completely rendered ANKH unable to enter the HEK293 cell mem-
brane and remained diffusely expressed within the cytoplasm at 24, 48 and 72 hours after transfection Fig. 3A). 
We measured a trending decrease in ePPi at 72 hours in HEK293 cells and observed a significant 40% increase in 
mineralization in CH-8 cells compared to wt.ANKH (Fig. 3B,C). In HEK293 cells we measured non-significant 
increases in ENPP1 and ENPP1 activity in CH-8 cells was found to increase at 24 hours but decrease at 48 hours 
(Fig. 3D,G). PIT-1 increased at 48 hours (Fig. 3F).
G389R slowed initial ANKH to insert in the membrane and trended to decrease ePPi, increased 
mineralization and was potentially targeted as a non-functional protein. G389R expressed 
mostly within the cytoplasm with just 28% of HEK293 cells displaying specific cell membrane localisation at 
24 hours, half that of the wild-type control, but show similar localisation after 48 hours, though there was novel 
vesicle like puncta (Fig. 4A). In HEK293 cells we found a non-significant decrease in ePPi at 48 and 72 hours. 
In CH-8 cells we measured small, though significant, increases in mineralization (Fig. 4B,C). G389R overex-
pressed in HEK293 cells was found to significantly increase of over two-fold ENPP1 early compared to wildtype 
at 24 hours (Fig. 4D), increased ENPP1 activity in CH-8 cells at 24 hours was also seen dropping from 48 hours 
(Fig. 4G). We also observed co-localisation of G389R-eGFP with RFP-LC3 under autophagic and rescue con-
ditions in HEK293 cells (Fig. 4H, zoomed and intensity over distance plots and Movie S3). We did not observe 
co-IP of LC3 with mutant G389R (Fig. 4I).
E490del mutated ANKH remained mostly cytoplasmic and formed punctate like structures 
that co-localised with LC3, and increased mineralization through increased expression of 
ENPP1, TNAP and PIT-1. E490del localised primarily to the cytoplasm at all time points, showing less than 
half of the membrane expression after 72 hours of wild-type control, and like G389R formed vesicle like puncta 
after 48 hours (Fig. 5A). The ePPi slowly increased over time at similar levels to wild-type with no significant 
difference. In CH-8 cells we observed a significant 15% increase in mineralization (Fig. 5B,C). Strikingly E490del 
increased expression of ENPP1 by over five-fold compared to wt.ANKH in the HEK293 cells, reflected by a 
five-fold increase in ENPP1 activity in CH-8 cells (Fig. 5D,G). This early expression at 24 hours is also seen in the 
two-fold increases of TNAP and PIT-1 (Fig. 5E,F). Similar to G389R we observed co-localisation of E490del-GFP 
with RFP-LC3 under autophagic and rescue conditions (Fig. 5H, zoomed and intensity over distance plots and 
Movie S4). We did not observe co-IP of LC3 with E490del (Fig. 5I).
Discussion
ANKH function at the cell membrane to transport PPi into the ECM is well established, however. We initially 
show ANKH localisation to the cell membrane to be non-homogenous and a striking distinction between the 
localisation dynamics of each ANKH mutants. P5L and G389R both localised more slowly to the cell membrane, 
E490del showed some cell membrane localisation but was mostly cytoplasmic and S375del did not at any time. 
A recent paper on novel mutant ANKH-F377del, also shows evidence of the mutated protein to be dispersed in 
the cytoplasm18. Although we see similar wt.ANKH localisation as reported by Kanaujiya, J. et al.18 and many 
other non-bone cell lines, we cannot discount the effects that this may be specific to bone. These very different 
localisation dynamics, even between mutants causing similar clinical features, highlights the complex and diverse 
function of ANKH in the pathogenesis of CPPDD and CMD.
We quantified each ANKH mutant effect on ePPi concentration and potentially non-physiological, mineraliza-
tion, and as expected overexpression of wt. ANKH increased ePPi level compared to endogenous ANKH, but the 
CPPDD linked gain-of-function P5L caused a remarkable increase of over double ePPi compared to wt.ANKH 
once a majority of the mutant had inserted into the cell membrane at 72 hours, suggesting a slowed response to 
ANKH changes in the pathophysiology, or even limited with sustained mutation expression. Conversely, both 
CMD linked loss-of-function S375del and G389R trended to decrease ePPi. In the ECM ePPi plays a key role in 
inhibiting HA accretion and bone mineralization2,7. In CMD, there is thought to be abnormal skeletal modelling 
due to excessive HA mineralisation because of the decrease in ePPi19, a phenotype confirmed by our novel molec-
ular data. In contrast, increased ePPi leads to excessive CPPD mineralization in the ECM of those suffering with 
CPPDD. Our data highlighted that all tested mutants had pathologically increased mineralization. Furthermore, 
the quantity of mineralization ranks the mutations in their severity of clinical phenotypes with S375del being 
the most severe, second P5L, third E490del and fourth G389R. Taken together, our data suggest a direct and 
novel link between differential cellular localisation, altered ePPi concentration and mineralization associated with 
mutated forms of ANKH.
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As bone mineralization is regulated by the ratio of [Pi]/[PPi] in the growth plate ECM, a synergistic relation-
ship between ANKH, ENPP1, TNAP and PIT-1 exists to control physiological vs. pathophysiological minerali-
zation2,20–23. We explored some of the reported interactions of ANKH with ENPP1, TNAP or PIT-1 in regulating 
Figure 2. P5L overexpression intracellular localisation and biochemical effects compared to wt.ANKH control 
in CH-8 and HEK293 cells. P5L-GFP (green) mainly localised to HEK293 cytoplasm at 24 H and cell membrane 
at 72 H (A); increased ePPi in HEK293 culture media (B); ARS staining of CH-8 cells (left) and concentration 
of ARS/µg protein (right) normalized to ActB confirming increased mineralization (C); no significant change 
in ENPP1 (D), significant increased TNAP at 24 H and trended increase at 72 H (E), no significant change in 
PIT-1 (F); ENPP1 activity in CH-8 cells increased at 24, 48 and 72 H (G). H = hours, scale bars = 20 μm; *** 
indicates p value < 0.01; * indicates p value < 0.05. # indicates p value < 0.1; neg. = Negligible/Raw value below 
threshold.
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ePPi and discerned the complexity of these relationships, especially in the context of disease progression and 
causality. Increased ENPP1 and PIT-1 of wt.ANKH corresponded to the increase in ePPi, and the reduction in 
TNAP was concordant with decreased mineralization. Therefore, simply increasing the quantity of ANKH did 
Figure 3. S375del overexpression intracellular localisation and biochemical effects compared to wt.ANKH 
control in CH-8 and HEK293 cells. S375del-GFP (green) localised to HEK293 cytoplasm at all time points 
(A); little change in ePPi concentration in culture media of HEK293 (B); ARS staining of CH-8 cells (left) and 
concentration of ARS/µg protein (right) normalized to ActB confirming increased mineralization (C); S375del 
in HEK293 cells trended to increase ENPP1 and TNAP at 24 H (D,E), significantly increased PIT-1 at 48 H (F); 
ENPP1 activity in CH-8 cells showed slightly increased at 24 H and decreased at 48 H (G). H = hours, scale bars 
= 20 μm; *** indicates p value < 0.01; * indicates p value < 0.05. # indicates p value < 0.1; neg. = Negligible/
Raw value below threshold.
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Figure 4. G389R overexpression intracellular localisation and biochemical effects compared to wt.ANKH 
control in CH-8 and HEK293 cells with no direct LC3 interaction. G389R-GFP (green) mainly localised to 
HEK293 cell membrane with many puncta (A); increased ePPi in HEK293 culture media (B); ARS staining 
of CH-8 cells (left) and concentration of ARS/µg protein (right) normalized to ActB confirming increased 
mineralization (C); G389R in HEK293 cells increased ENPP1 at 24 H (D), did not significantly change of TNAP 
and PIT-1 at any time (E,F), ENPP1 activity in CH-8 cells increased at 24 H, then decreased at 48–72 H (G); Live 
confocal G389R ANKH-GFP (green) and RFP-LC3 (red) showing co-localisation during autophagy induction 
and rescue (circled) confirmed with intensity over distance (dotted line) (H); HEK293 Lysates of G389R 
ANKH-GFP and RFP-LC3 (rep of three) at 24 H, with autophagic media for 3 h (A), with normal growth media 
for 24 H (R); top: anti-GFP Western blot of IP GFP pull down, shows G389R not physically interact with LC3 
(I). H = hours, scale bars = 20 μm; *** indicates p value < 0.01; * indicates p value < 0.05. # indicates p value 
< 0.1; neg. = Negligible/Raw value below threshold.
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Figure 5. E490del overexpression intracellular localisation and biochemical effects of compared to wt.ANKH 
control in CH-8 and HEK293 cells with no direct LC3 interaction. E490del ANKH-GFP (green) localised 
mainly to cytoplasm and formed puncta at 24, at 72 H majority in membrane (A); increased ePPi in HEK293 
culture media (B); ARS staining of CH-8 cells (left) and concentration of ARS/µg protein (right) normalized to 
ActB confirming increased mineralization (C); E490del in HEK293 cells increased ENPP1 and TNAP at 24 H 
(D,E); increased PIT-1 at 24–48 H (F); increased ENPP1 activity in CH-8 cells at 24 h (G); Live confocal E490del 
ANKH-GFP (green) and RFP-LC3 (red) showing co-localisation during autophagy induction and rescue 
(circled) confirmed with intensity over distance (dotted line) (H); HEK293 Lysates of E490del ANKH-GFP and 
RFP-LC3 (rep of three) at 24 H, with autophagic media for 3 h (A), with normal growth media for 24 H (R); top: 
anti-GFP Western blot of IP GFP pull down, shows E490del not physically interacting with LC3 (I). H = hours, 
scale bars = 20 μm; *** indicates p value < 0.01; * indicates p value < 0.05. # indicates p value < 0.1; neg. = 
Negligible/Raw value below threshold.
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not replicate a gain-of-function phenotype. This is likely due to saturation of the ANKH - ENPP1 interaction, 
where ENPP1 is thought to provide most of the ePPi present in the ECM24–26. The decrease in mineralization 
can be attributed to the mild increase in ePPi, enough to further inhibit HA accretion but insufficient for CPPD 
formation.
P5L increased expression of TNAP at 24 hours as a response to increased ePPi, but not sustained; however 
the level of ENPP1 and PIT-1 were similar to wt.ANKH. Interestingly, we measured an increase in ENPP1 activ-
ity at 24, 48 and 72 hours, and therefore we suggest that P5L raised ePPi via increased ENPP1 activity rather 
than increased ANKH function or increased ENPP1 expression – enlightening the previous observation showing 
P5L to increase activity of ENPP18. Furthermore, the increased ePPi and non-changed PIT-1 indicated that the 
increased mineralization caused by P5L was specific to CPPD formation rather than HA. Inability of S375del 
to insert into the membrane was so severe that even increased expression of ENPP1, TNAP, PIT-1 and cor-
responding ENPP1 activity as compensation was not enough to rescue the phenotype. S375del showed by far 
the largest mineralization profile and decrease in ePPi over time indicated the mineralization to be likely HA 
rather than CPPD. In the long term, reduced ANKH membrane presence would exacerbate a condition reliant 
on extracellular ePPi control and this explains the severe phenotype. The milder phenotype G389R increased 
expression and corresponding activity of ENPP1 but did not change TNAP and PIT-1. Interestingly, as G389R 
was recruited to the cell membrane similar to wt.ANKH but still increased ENPP1 activity and expression as 
compensation for decreasing ePPi levels, this suggested a severe reduction in transport capability for G389R but 
needs further exploration. E490del drastically increased early expression of ENPP1, TNAP and PIT-1 and corre-
sponding ENPP1 activity as compensation for lack of ANKH at the cell membrane, however as this mutant did 
not completely abolish ANKH localisation and hence, the compensatory effect seemed to be overpowered and 
might indeed be causal in the pathogenesis of CPPDD in sufferers affected by the E490del mutation, requiring 
further study.
Abnormal or defective proteins are often targeted by autophagic machinery for recycling27. Co-localisation 
of the autophagy marker LC3 with E490del under normal, autophagy induction and rescue conditions, and with 
G389R under autophagy induction and rescue conditions could suggest that these mutated proteins were targeted 
as non-functional or defective proteins. We also checked for direct physical interaction of ANKH with LC3, which 
may indicate a role in the autophagy process, however we did not observe co-IP of these mutants with LC3, mak-
ing it more likely that G389R and E490del were targets of autophagy as non-functional or defective proteins rather 
than facilitators in the autophagy process. The absence of co-localisation for P5L and S375del does not suggest 
they are not recycled as this process is not limited to autophagy, for example an endoplasmic-reticulum-associated 
protein degradation (ERAD) ubiquitination pathway that is preferential for insoluble aggregates within the cyto-
plasm could explain no co-localising of S375del with LC327.
We summarize the possible mechanisms in the pathogenesis of each tested mutants associated with CPPDD 
or CMD as follows:
P5L. This proline to leucine mutation may delay ANKH membrane uptake and the longer term increasing 
in ePPi could be attributed to an overreaction from increased ENPP1 activity rather than ENPP1 expression 
directly. This is likely that the rise in ePPi is not due to increased ENPP1 amounts at the cell membrane but rather 
to increased activity of ENPP1 that is already at the cell membrane facilitated by the P5L mutation as suggested 
by previous work and now also our ENPP1 activity assay. Since TNAP expression increased initially and has a 
role in reducing excess ePPi, we suggest that there should be a feedback mechanism to upregulate TNAP under 
conditions of high ePPi but cannot compensate for the mutation effect.
S375del. Our data suggests that deletion of serine at residue 375 completely abolishes ANKH localisation to 
the cell membrane and is a loss-of-function. We observed almost cytoskeletal-like localisation over 72 hours and 
measured a corresponding decrease in ePPi and increase in mineralization. The phenotype of S375del CMD is 
severe and at the molecular level even the compensatory increase in ENPP1, TNAP and PIT-1 could not rescue the 
biochemical phenotype. Mechanistically, we predict the serine deletion results in inappropriate trafficking from 
the ER and abolishes ANKH function.
G389R. This mutant displayed equivocal molecular data highlighting its variable clinical associations with 
both CMD and CPPDD. Its cell membrane localisation resembled the CPPDD-associated mutant P5L but we 
measured a sustained decrease in ePPi similar to the CMD associated mutant S375del. Early upregulation of 
ENPP1 under low ePPi concentrations further supports this to be a loss-of-function mutation. Hence, since the 
mutant successfully localised to the cell membrane, the glycine to arginine change at residue 389 appears to cause 
a loss of transport channel function, which caused the decrease in ePPi and increase in mineralization, although 
small, reflecting its milder phenotype. The involvement of G389R in autophagy also suggests that it undergoes 
mis-folding or some other abnormal processing, but perhaps to a lesser degree than E490del.
E490del. The deletion of a glutamate residue at the C-terminus renders it unable to insert effectively into the 
cell membrane. However, this mutant functioned similar to wt. ANKH in regulating ePPi by increasing ENPP1, 
TNAP and PIT-1 but was still pathogenic as it increased mineralization. We suggest that this mutant is recognised 
as a non-functional protein and is constantly recycled by the autophagy machinery, which consequently due to 
its loss also upregulates ENPP1, TNAP and PIT-1 as compensation for the loss of ANKH at the cell membrane. It 
is noteworthy that the clinical presentation of CPPDD associated with the E490del is less severe than other forms 
that might be due to some of the ANKH getting to the membrane but at lower efficiency.
In summary, the corresponding pathogenetic mechanisms for each of the ANKH terminal CPPDD and cen-
tral CMD associated mutations appear to be unique even between mutants causing similar phenotypes which 
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are potentially associated with the levels of disease severity. They include effects on intracellular trafficking of 
ANKH, PPi transport channel function, mineralization, ENPP1 activity regulation, autophagy and guiding effects 
in expression level of ENPP1, TNAP and PIT-1, some of which could represent tractable targets for therapy.
Methods
Cell culture and plasmid transfection. CH-8 articular chondrocyte and HEK293 cells were cultured in 
high glucose DMEM supplemented with 10% FBS and 1% penicillin-streptomycin. Transfections were performed 
using FugeneHD (Promega, Wisconsin, USA). Transfections were optimised by counting the number of GFP 
expressing cells in at least 3 distinct fields of views and expressed as a percentage of transfected vs. non-trans-
fected cells (Fig. S4).
ANKH construct and mutant generation. Standard restriction cloning was used to create 
NM_054027.4:ANKH-eGFP_N3 (wt.ANKH)) and NM_054027.4:ANKH-eGFP_C1 (wt.ANKH_C1) overexpres-
sion constructs. A Q5 Site-Directed mutagenesis kit (New England BioLabs, Massachusetts, USA) was used to cre-
ate the desired overexpression mutants with the following primers; P5L: 5′-GTGAAATTCCTGGCGCTCACG, 
3 ′ – C AT G G A AT T C G A A G C T T G A G C ;  E 4 9 0 d e l :  5 ′ – A AT G A A A AT G G AT C C AT C G C , 
3′–CTCTCTCATTTCCACGATG; S375del: 5′–TTCTTCCCAGTTCCAGTC, 3′–GAAGATCCGCAAAGGAAC; 
G389R: 5′–GCATCTCACCAGGTGGCTGATG, 3′–GCCCTCACTGTGACTGGA. For all experiments 
wt.ANKH was measured against empty eGFP construct and mutants against wt.ANKH.
Confocal Imaging. CH-8 and HEK293 cells were cultured on 35 mm high glass bottom u-dishes (iBidi, 
Martinsried, Germany). Before visualisation, cells were PBS washed and fresh growth media added. Nuclear 
DNA was stained with Hoechst 33342 (5 ug/ml) (Thermo Fisher) for 10 mins. Confocal imaging was performed 
on a Zeiss LSM 880 with Airyscan with a temperature and CO2 controlled chamber. Images were processed on 
proprietary Zen 2.1 (Zeiss, Jena, Germany).
Autophagy induction and rescue. HEK293 cells were grown to 60% confluence and co-transfected 
with pmRFP_LC3 (autophagy marker, red) and wt. or mutant ANKH_eGFP. Autophagy was induced for three 
hours, replacing with fresh culture media, supplemented with 250 nM rapamycin, without essential amino acids. 
Cells were rescued at 24 hours in normal growth media and imaged. Intensity over distance was measured for 
co-localisation of mutants with LC3 in Zen through overlapping puncta, measuring raw arbitrary intensity plot-
ted against distance28. Samples were blinded and cell counting was performed via tiling an 8 × 8 (1.68 mm2) area 
and counting transfected expressed cells (n > 100) recording cells with either cell membrane expression or cyto-
plasmic expression only, reported as a percentage of cells with only cell membrane expression.
Inorganic pyrophosphate assay. Culture media from transfected and control CH-8 and HEK293 
cells were collected every 24 hours and the concentration of PPi measured using the PPiLight Pyrophosphate 
Detection Kit (Lonza, Basel, Switzerland). Arbitrary luminescence was recorded on a MicroBeta TriLux 1450 
(Perkin Elmer, Massachusetts, USA) reader using a 0.1 s integrated read time29,30. Results were normalised to the 
native non-cellular fluctuation in media only and concentration was deduced by plotting a standard curve.
Alizarin red S mineralization assay. CH-8 cells were cultured to 60% confluence and transfected with 
wt.ANKH, mutants or GFP only plasmid, The media was replaced with mineralization media consisting of high 
glucose DMEM supplemented with 10% FBS, 50 ug/ml Ascorbic acid, 10 mM B-glycerol phosphate (BGP) and 
100 nM dexamethasone 24 hours after transfection and the cells were incubated for another 48 hours. The miner-
alization measured by ARed-Q (Sciencecell Research Laboratories, CA, USA).
Quantitative PCR. Transfected CH-8 and HEK293 cells were scraped at 24, 48 and 72 hours and RNA extracted 
by RNeasy Kit (Qiagen, Hilden, Germany). cDNA was synthesized using iScript and qPCR performed using SYBR 
Green Kits (both Bio-Rad, California, USA). QPCR Primers ENPP1: F–GGTGGACTTCTTCCTGTTATTA, 
R – G G T G A C A A T G C T G TA G T G A ;  T N A P :  F – G C T T G A C C T C C T C G G A A G A C ,  R –
GGGGCCAGACCAAAGATAGA; PIT-1: F–GACTGGCGTCTCTTTCGTA, R–ATGATGGCAGCACTGATAAC; 
ACTB: F–TGACCCAGATCATGTTTGAGA, R-TACGGCCAGAGGCGTACAGC.
ENPP1 enzyme activity assay. Transfected CH-8 cells were harvested as pellets via scraping at 24, 48 and 
72 hours. The colourimetric substrate p-nitrophenyl thymidine 5′-monophosphate (Sigma, Welwyn Garden City, 
UK) was assessed following a published protocol24.
Co-immunoprecipitation (co-IP) and western blotting. CH-8 and HEK293 cells were co-transfected 
with relevant plasmid at 60% confluence. Co-IP was performed using GFP-Trap magnetic agarose beads that 
implement a unique camelid nanobody (Chromotek, Martinsried, Germany). SDS PAGE was performed on the 
lysates and pull downs in 4–20% TGX protein gels, transferred to a PVDF membrane, blocked for 1 hour in 5% 
milk/TBS/0.1% tween20 and probed with 1:2500 anti-GFP antibody (NB600-308, R&D Systems, Abingdon, UK), 
1 µg/ml anti-LC3 (NB100-2220, R&D Systems) and 1:5000 anti-GAPDH (AB128915, Abcam) overnight at 4 °C 
in 5% milk/TBST. Goat anti-rabbit IgG-HRP (AB97051, Abcam, Cambridge, UK) 1:5000 secondary was incu-
bated for 1 hour in 5% milk/TBST at room temperature and detected using Clarity ECL western substrate on a 
ChemiDoc XRS + (all Bio-Rad). Full gels are in the Supplementary Figs. 5–7.
Statistical analysis. All experiments were repeated a minimum of three times. For the chemical data anal-
ysis, wt.ANKH effect was compared to null vector control whilst mutant effect was compared to wt.ANKH. 
Assuming equal variance, 2-tailed t-test was used to evaluate significance for normally distributed data, whilst a 
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Mann-Whitney u-test was performed on non-normally distributed data. An F-test was performed to check equal 
and unequal variance. Statistical significance was set at p < 0.05. We use # to highlight the data 0.05 < p < 0.1, 
*p < 0.05, **p < 0.01, ***p < 0.0005.
Data availability
Materials and data are available with reasonable request from the corresponding author.
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